Gonorrhea is one tough germ to beat Over the past  years the bug has outwitted four classes of antibiotics leaving just one set of drugs available to kill it Now theres more evidence that the arsenal against gonorrhea is shrinking again Canadian doctors have documented the first failure in North America of cefixime the frontline antibiotic for   Although the study was small  the doctors looked at only  cases total  nearly  percent of patients failed to be cured by the standard dose of   sold under the brandname Suprax The findings are   in the current issue of   the Weve heard of such cases in   and Europe Now its happening in North America   of the US Centers for Disease Control and Prevention tells Shots Its very concerning Gonorrhea is the secondmost common sexually transmitted disease in the US with more than  cases reported in  People are often surprised that gonorrhea is still around Kirkcaldy says Its an ancient disease but its surprisingly common in some parts of the US So far there have been no treatment failures in the US Kirkcaldy says Our treatment option in the US is still highly effective And even in the Canadian study all patients eventually recovered when they were given larger doses of cefixime or a related antibiotic Nevertheless there have been worrying signs of antibioticresistant gonorrhea in the US For decades CDC scientists have been keeping a close eye on gonorrhea strains around the country Theyve taken samples of the bugs from patients and tested how much cefixime is needed to kill them in the lab The effective dose of cefixime has   slowly over the past ten years The CDC got concerned enough about the trend in August that officials told doctors to   using cefixime altogether and switch to a related drug called ceftriaxone or Rochephin The CDC is looking to preserve cefiximes effectiveness Some doctors like   of Public Health Ontario worry that gonorrhea will quickly acquire resistance to this other antibiotic as well especially since it works by a similar mechanism as cefixime We need to rethink our strategy of antibiotic use Allen who led the   study tells Shots We dont have luxury of just switching to another antibiotic she says because there really arent any more left for gonorrhea